Indication

Herpes labialis

Herpes labialis is a recurrent viral infection of the perioral region and lips, most commonly caused by herpes simplex virus type 1 (HSV-1) and less frequently by herpes simplex virus type 2 (HSV-2). Read more about Herpes labialis

109 drugs 87 manufacturers

Advertisement

Drugs that treat it

Common Herpes labialis therapies.

Showing 28–36 of 109 drugs

ACYCLOVIR

ANTIVIRAL - HERPES VIRUSES·CHICKENPOX·+9
Major Pharamceuticals

ACYCLOVIR

ANTIVIRAL - HERPES VIRUSES·CHICKENPOX·+9
AHP
Filter & compare in the drug finder →Opens the drug finder with Herpes labialis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Herpes labialis.

Herpes labialis is a recurrent viral infection of the perioral region and lips, most commonly caused by herpes simplex virus type 1 (HSV-1) and less frequently by herpes simplex virus type 2 (HSV-2).

Affecting the mucocutaneous tissues of both pediatric and adult populations, the condition arises when the dormant virus reactivates within the trigeminal sensory ganglion and travels anterograde along peripheral nerves to the cutaneous epithelium.

Clinically, episodes are typically preceded by a sensory prodrome of tingling, burning, or itching, followed by the eruption of clustered, painful, fluid-filled vesicles on an erythematous base that ulcerate, crust, and spontaneously resolve over several days.

Personalize your experience

Follow Herpes labialis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it